Using a database to discover and develop a drug will deliver cures faster than the traditional medical research model.
Combining genomic and phenotypic data is expected to reach several objectives, such as identifying new drug targets, tackling new subsets of disease and enabling rapid progression of clinical programs, all these processes in less time and with a higher level of efficiency.
Drug targets can be leading information for the R&D process in order to define priorities based on strength of the biological hypothesis, to find clinical opportunity and increase the possibility of developing novel medicines.
Is with our research and results that we want to build people’s trust in our actual technology and in the development of novel pharmaceutical solutions.
Maintaining transparency as a core tenet of the company and operating under our human ethical review board, we want to deserve the trust that people already showed to us and that we will defend in the future.
Sensitive data protection is a crucial argument of this historical moment and we know that the safety of personal information has to be protected by also a higher level of public scrutiny.
TIME TO GET STARTED
Input your search keywords and press Enter.